Currently out of the existing stock ratings of Trung Huynh, 9 are a HOLD (36%), 14 are a BUY (56%), 2 are a SELL (8%).

Trung Huynh

Work Performance Price Targets & Ratings Chart

Analyst Trung Huynh works at UBS with a stock forecast success ratio of 48.15% fulfilled within 84.78 days on average.

Trung Huynh’s has documented 56 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 20-Oct-2023.

Wall Street Analyst Trung Huynh

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/28/2023. The price target of $420 was fulfilled within 5 days with a profit of $27.43 (6.99%) receiving and performance score of 13.97.

Average potential price target upside

GRFS Grifols SA ADR BMY Bristol-Myers Squibb Company AMGN Amgen MRK Merck mpany JNJ Johnson & Johnson LLY Eli Lilly and Company LBTSF Almirall PFE Pfizer RHHBY Roche Holding Ltd ADR AZN AstraZeneca PLC ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

27.53

$20.24 (277.64%)

19.07

11 months 12 days ago

0/11 (0%)

$20.09 (270.03%)

Buy

17.25

$9.96 (136.63%)

21

11 months 12 days ago

0/6 (0%)

$9.81 (131.85%)

Hold

18.36

$11.07 (151.85%)

9.34

1 years 2 months 30 days ago

2/6 (33.33%)

$9.15 (99.35%)

46

Hold

9.09

$1.8 (24.69%)

12.5

1 years 3 months 14 days ago

3/3 (100%)

$0.35 (4.00%)

65

Hold

9.91

$2.62 (35.94%)

16.32

1 years 5 months 23 days ago

1/6 (16.67%)

$3.81 (62.46%)

105

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Trung Huynh?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?